Jan 24, 2020 New transparency obligations for medical device companies in Italy By Mark Franklin Nicola Landolfi On 1 January 2021, important transparency obligations provided for in the Code of Ethics of Confindustria Dispositivi Medici (the Italian...
Feb 04, 2019 PureTech Health summit bringing Brain Immune Gut research together By DLA Piper The final session at BIG was entitled Turning Pharma on its Head: The Next Big Thing. There was discussion of particular technologies...
Feb 04, 2019 Day 2 Puretech Health - BIG Summit By DLA Piper Fascinating and inspiring presentations at BIG about the brain-gut axis and the key role of all mucosal immune systems in CNS related...
Jan 25, 2019 BIG (Brain-Immune-Gut) Summit January 2019 By DLA Piper I am really looking forward to attending this conference; not just because it is in Aruba!. There is very exciting science happening on...
Apr 05, 2018 The Consero IP Forum for Life Sciences: a great opportunity for sharing knowledge By Roberto Valenti Between 9 and 11 April I will be in Basilea with Johan Renes from DLA Piper Amsterdam and Paula Gonzalez from DLA Piper Madrid at the...
Mar 19, 2018 Some Brexit clarity.....to end of 2020 By DLA Piper A Brexit transition period to 31 December 2020 is good news for the Life Sciences industry. Brexit negotiators have now agreed Article...
Mar 13, 2018 Publishing Clinical Data under Policy 0070 By DLA Piper We have been looking closely at the EMA requirements for publishing clinical data under Policy 0070. There is an expanding body of...
Mar 12, 2018 What’s in a name? The Latest Considerations in Naming Biosimilars By Roberto Valenti Really looking forward to meeting you at the IP Forum for Life Sciences in April. I will be hosting a discussion with tregard to naming...
Mar 06, 2018 Northern Powerhouse going global By DLA Piper Tomorrow I will be on stage at 11 am discussing 'Growing Global' at the Northern Powerhouse Health Innovation Conference 2018. The first...
Nov 17, 2017 Checkpoint Inhibitors and Diabetes By Lisa Haile PD-L1 and checkpoint inhibitors have been front and center in the media relating to the treatment of cancer. Researches are now looking...
Nov 17, 2017 Regulating High Cholesterol-A Never Ending Challenge By Lisa Haile Researchers from Harvard identified a new protein, Nrf1, which regulates high cholesterol by binding directly to it. This binding prompts...
Nov 17, 2017 Human Embryonic Stem Cells to Treat Blindness By Lisa Haile We have been hearing for a decade about the use of stem cells to create organs and treat diseases. Today, a study showing that hES cells...
Nov 14, 2017 Sanofi Enters the Race to Develop a New Drug for Multiple Sclerosis By Lisa Haile Sanofi has paid big bucks to enter the race to develop a new drug for MS. The drug was developed by Principia Biopharma and crosses the...
Nov 06, 2017 Do you know the top 10 most popular m-Health apps? By Marina Rubini The m-Health market will reach approx. $ 26 billion globally by 2017 with a number of m-Health apps downloaded worldwide of about 3.2...
Nov 03, 2017 Taxing pads and tampons (or not). The Canary Islands innovate. By Diego Ramos The regional government of the Canary Islands has decided to cut off the local value added tax applicable to sanitary pads and tampons....
Nov 01, 2017 Doctrine of equivalents: what's new in Continental Europe? By Roberto Valenti For the first time, in Eli Lilly v Actavis the UK Supreme Court has introduced a doctrine of equivalence in an effort to move closer to...